Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Vose

Showing results (81-90 of 299) with videos related to

Pageof 30
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantationWillis H Navarro, Fausto R Loberiza, Ruta Bajorunaite, et al.
American Journal of Hematology|August 13, 2004
Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphomaMarin Nola, Steven Z Pavletic, Dennis D Weisenburger, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 29, 2016
Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results DatabaseVijaya Raj Bhatt, Smith Giri, Vivek Verma, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 19, 2013
Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphomaBasem M William, Fausto R Loberiza, Victoria Whalen, et al.
JCO Oncology Practice|April 7, 2023
ASCO Policy Statement on Biosimilar and Interchangeable Products in OncologyGladys Rodriguez, Joan Mancuso, Gary H Lyman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2007
Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic IndexJulie M Vose, Philip J Bierman, Fausto R Loberiza, et al.
Molecular Cancer Therapeutics|August 22, 2013
Novel treatment for mantle cell lymphoma including therapy-resistant tumor by NF-κB and mTOR dual-targeting approachNagendra K Chaturvedi, Rajkumar N Rajule, Ashima Shukla, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2014
Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphomaBasem M William, Mary S Allen, Fausto R Loberiza, et al.
Leukemia & Lymphoma|September 23, 2010
Association of number of follow-up providers with outcomes in survivors of hematologic malignanciesAnthony J Cannon, Deborah L Darrington, Helen E McIlvain, et al.
Leukemia & Lymphoma|January 7, 2009
Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphomaJohn M Timmerman, Julie M Vose, Debra K Czerwinski, et al.
Pageof 30

Showing results (81-90 of 299) with videos related to

Sort By:
Pageof 30
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 26, 2006
Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantationWillis H Navarro, Fausto R Loberiza, Ruta Bajorunaite, et al.
American Journal of Hematology|August 13, 2004
Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphomaMarin Nola, Steven Z Pavletic, Dennis D Weisenburger, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 29, 2016
Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results DatabaseVijaya Raj Bhatt, Smith Giri, Vivek Verma, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 19, 2013
Impact of conditioning regimen on outcome of 2-year disease-free survivors of autologous stem cell transplantation for Hodgkin lymphomaBasem M William, Fausto R Loberiza, Victoria Whalen, et al.
JCO Oncology Practice|April 7, 2023
ASCO Policy Statement on Biosimilar and Interchangeable Products in OncologyGladys Rodriguez, Joan Mancuso, Gary H Lyman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2007
Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic IndexJulie M Vose, Philip J Bierman, Fausto R Loberiza, et al.
Molecular Cancer Therapeutics|August 22, 2013
Novel treatment for mantle cell lymphoma including therapy-resistant tumor by NF-κB and mTOR dual-targeting approachNagendra K Chaturvedi, Rajkumar N Rajule, Ashima Shukla, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2014
Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphomaBasem M William, Mary S Allen, Fausto R Loberiza, et al.
Leukemia & Lymphoma|September 23, 2010
Association of number of follow-up providers with outcomes in survivors of hematologic malignanciesAnthony J Cannon, Deborah L Darrington, Helen E McIlvain, et al.
Leukemia & Lymphoma|January 7, 2009
Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphomaJohn M Timmerman, Julie M Vose, Debra K Czerwinski, et al.
Pageof 30